glenmark pharmaceuticals: Glenmark Pharma to raise up to $200 million - The TheIndianSubcontinentNever miss a great news story!Get instant notifications from TheIndianSubcontinentAllowNot nowYou can switch off notifications anytime using browser settings.NewsStock Analysis, IPO, Mutual Funds, Bonds - MoreThe proposal was approved at the company's annual general meeting held on September 27.
PTI|Sep 28, 2019, 03.44 PM ISTGetty ImagesThe price at which the debt securities will be issued shall be determined by the board in accordance with applicable laws and consultation with appropriate advisors, it added.
Glenmark Pharmaceuticals on Saturday said its shareholders have approved a proposal to raise up to $200 million (about Rs 1,413 crore) through issuance of debt securities.
The proposal was approved at the company's annual general meeting held on September 27.
"All the Resolutions were declared passed with the requisite majority," the company said in a BSE filing.
According to the proposal, the firm plans to raise up to $200 million in Indian and/or international market through bonds, debentures or other debt securities in one or more tranches.
The price at which the debt securities will be issued shall be determined by the board in accordance with applicable laws and consultation with appropriate advisors, it added.
Commenting feature is disabled in your country/region.Browse CompaniesABCDEFGHIJKLMNOPQRSTUVWXYZ|123456789To see your saved stories, click on link hightlighted in bold
Stock Market
Unlimited Portal Access + Monthly Magazine - 12 issues-Publication from Jan 2021 |
Buy Our Merchandise (Peace Series)
- Details
- Category: Stock Market
21